-
公开(公告)号:EP3454884A1
公开(公告)日:2019-03-20
申请号:EP17725893.6
申请日:2017-05-10
申请人: Sorbonne Université , Centre National de la Recherche Scientifique , INSERM - Institut National de la Santé et de la Recherche Médicale
-
公开(公告)号:EP3551211A1
公开(公告)日:2019-10-16
申请号:EP17826163.2
申请日:2017-12-12
申请人: Sorbonne Université , Centre National de la Recherche Scientifique , INSERM (Institut National de la Santé et de la Recherche Médicale) , INSTITUT PASTEUR DE TUNIS
-
公开(公告)号:EP3394100A1
公开(公告)日:2018-10-31
申请号:EP16819574.1
申请日:2016-12-23
申请人: Sorbonne Université , Centre National de la Recherche Scientifique , INSERM (Institut National de la Santé et de la Recherche Médicale)
IPC分类号: C07K16/28
CPC分类号: C07K16/2845 , A61K2039/505 , A61K2039/54 , C07K2317/76
摘要: The present invention relates to agents inhibiting the interaction between CFH and CD11b/18. The present invention also relates to the use of said agents, in particular for treating inflammatory disorders, such as age-related macular degeneration.
-
公开(公告)号:EP3096781A1
公开(公告)日:2016-11-30
申请号:EP15701194.1
申请日:2015-01-22
申请人: Université Pierre et Marie Curie - Paris 6 (UPMC) , Centre National de la Recherche Scientifique (C.N.R.S.)
IPC分类号: A61K39/00
CPC分类号: C07K16/248 , A61K45/00 , C07K16/2866 , C07K2317/76
摘要: The present invention relates to preventive and/or therapeutic agents for use in the treatment of retinal inflammation, and more specifically of Age-related macular degeneration and Retinitis pigmentosa, wherein said agents are selected from an IL-6 inhibitor, an APOE inhibitor and/or a Fas activator as an active ingredient.
-
-
-